The Supreme Court of India has exempted the painkiller tablet Saridon from the list of banned FDCs (Fixed Dose Combinations) in India - what many see as a sigh of relief for the Piramal Enterprises.
Last year, in September, the Health Ministry had banned the manufacture, sale and distribution of 328 fixed-dose combinations (FDCs) of drugs. The ban included popular drugs like skin cream Panderm, painkiller Saridon, antibacterial Taxim AZ, antibiotic Lupidiclox, and combination diabetes drug Gluconorm PG.
Many popular cold medicines, cough syrups, and painkillers are combination drugs, containing two or more therapeutic ingredients in a single dose. Saridon is marketed as a treatment for headaches. The medicine is the largest selling painkiller in India with sales of nearly Rs 100 crore as reported by Economic Times.
An Appeal...
Dear Reader,
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.